Total Live Articles: 475

Attention Deficit Hyperactivity Disorder (ADHD)

NICE guideline [NG87] Attention deficit hyperactivity disorder: diagnosis and management. Last updated: Sep 2019.

Attention Deficit Hyperactivity Disorder (ADHD)

General Psychiatry Article Disclaimer

  • DSM-5 criteria or ICD-11 diagnostic requirements are used to structure the Clinical Features and Diagnosis section. The classification system used is selected according to its clarity and suitability for non-specialist learning.
  • The criteria are summarised and simplified rather than reproduced in full, while preserving their original diagnostic meaning.
  • Where appropriate, a student-friendly pattern-recognition summary is provided to highlight the most clinically and exam-relevant features.

Exam tip (re-psychiatry questions)

  • Do not attempt to memorise every DSM-5 or ICD-11 criterion word-for-word. However, it is important to read through the criteria and become familiar with the key symptom clusters, duration thresholds, exclusions, and distinguishing features highlighted in this article.
  • Exam questions may not provide every feature required to meet the full diagnostic criteria. Familiarity with the criteria can help one recognise the most likely diagnosis, exclude important alternatives, and narrow the differential diagnosis.

Causes and Risk Factors

ADHD is a multifactorial condition arising from a combination of genetic and environmental factors [Ref]

Possible factors include: [Ref]

  • Polygenic contribution (ADHD is rarely caused by a single-gene mutation or chromosomal abnormalities)
  • Pregnancy and birth-related factors
    • Prematurity
    • Very low birth weight
    • Maternal pre-eclampsia / hypertension
    • Maternal obesity
    • Maternal thyroid disorders
    • Multiple prior miscarriages
  • Prenatal or childhood exposure to environmental toxins, such as
    • Organophosphate pesticides
    • Lead
    • Phthalate metabolites
    • Maternal use of sodium valproate and paracetamol during pregnancy
  • Psychosocial and extreme adversity (e.g. severe early deprivation, physical neglect, sexual abuse, low family income, out-of-home care, and familial exposure to severe substance abuse or criminality)

Associated Conditions / Comorbidities

ADHD is associated with the following: [Ref]

Category Specific conditions / comorbidities
Psychiatric and neurodevelopmental ADHD often co-exists with the following:

  • Behavioural disorders (e.g. conduct disorder, oppositional defiant disorder)
  • Neurodevelopmental disorders (e.g. autism spectrum disorder, learning disability / difficulty, tic disorders)
  • Mood and anxiety disorders (e.g. depression, bipolar disorder, anxiety, OCD, PTSD)
  • Other psychiatric conditions (e.g. eating disorder, schizophrenia, personality disorder)
Substance use disorder
  • Nicotine dependence
  • Alcohol use disorder
  • Drug use disorder
Metabolic and endocrine
  • Obesity
  • Diabetes
  • General metabolic disorders and testicular dysfunction
Respiratory, immune and autoimmune
  • Atopy (e.g. atopic dermatitis / eczema, allergic rhinitis, asthma)
  • Autoimmune disease (e.g. ankylosing spondylitis, ulcerative colitis, autoimmune thyroid disease)
  • Infections (e.g. STIs, viral pneumonia, hospitalisation for serious general infections)
Neurological and sleep
  • Epilepsy
  • Migraines
  • Sleep problems (e.g. sleep-disordered breathing, prolonged time to fall asleep, frequent night awakenings, and overall worse sleep quality)

Clinical Features and Diagnosis

High-yield pattern recognition for ADHD:

ADHD may present from either or both of the following 2 core symptom domains:

  • Inattention, classic features include:
    • Frequent careless mistakes or poor attention to detail
    • Appearing not to listen when spoken to
    • Starting but failing to complete tasks
    • Frequently losing essential items
    • Being easily distracted
    • Forgetfulness in daily activities
  • Hyperactivity-impulsivity, classic features include:
    • Hyperactivity
      • Difficulty engaging in activities quietly
      • Restlessness or excessive activity (e.g. difficulty remaining seated, excessive running, fidgeting or squirming)
      • Appearing constantly active or “driven by a motor”
      • Excessive talking
    • Impulsivity
      • Blurting out answers
      • Difficulty waiting their turn
      • Interrupting or intruding on others

The symptoms above must also meet ALL of the following criteria:

  • Persisted for at least 6 months
  • Several symptoms should have been present before 12 y/o
  • Symptoms occur in at least 2 different settings (e.g. home, school, work)
  • Impacts social, educational, or occupational functioning
  • Not be better explained by another mental disorder

According to the DSM-5 criteria, ADHD can be clinically diagnosed when ALL the following criteria are met: [Ref]

Diagnostic criteria Criteria description
Persistent ADHD symptoms One or both of the following 2 symptom domains must be met

For either symptom domain, there should be at least 6 out of 9 symptoms that:

  • Persisted for at least 6 months
  • Inconsistent with the person’s developmental level
  • Negatively affect social, educational, or occupational functioning

For those who are ≥17 y/o, only 5 symptoms are required

Symptom domain 1: inattention

  • Fails to give close attention to details or makes careless mistakes in schoolwork, at work, or during other activities (e.g. overlooks or misses details, inaccurate work)
  • Difficulty sustaining attention in tasks or play activities (e.g. difficulty remaining focused during lectures, conversations, or lengthy reading)
  • Does not seem to listen when spoken to directly (e.g. mind seems elsewhere, even in the absence of any obvious distraction)
  • Does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace (e.g. starts tasks but quickly loses focus and is easily sidetracked)
  • Difficulty organising tasks and activities (e.g. difficulty managing sequential tasks; difficulty keeping materials and belongings in order; messy, disorganised work; has poor time management; fails to meet deadlines)
  • Avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (e.g. schoolwork or homework; for older adolescents and adults, preparing reports, completing forms, reviewing lengthy papers)
  • Loses things necessary for tasks or activities (e.g. school materials, pencils, books, tools, wallets, keys, paperwork, eyeglasses, mobile telephones)
  • Easily distracted by extraneous stimuli (for older adolescents and adults, may include unrelated thoughts)
  • Forgetful in daily activities (e.g. doing chores, running errands; for older adolescents and adults, returning calls, paying bills, keeping appointments)

Symptom domain 2: hyperactivity-impulsivity

  • Hyperactivity
    • Fidgets with or taps hands or feet or squirms in seat
    • Leaves seat in situations when remaining seated is expected (e.g. leaves his or her place in the classroom, in the office or other workplace, or in other situations that require remaining in place)
    • Runs about or climbs in situations where it is inappropriate (for older adolescents and adults, may be limited to feeling restless)
    • Unable to play or take part in leisure activities quietly
    • Often “on the go” acting as if “driven by a motor” (e.g. unable to be or uncomfortable being still for extended time, as in restaurants, meetings; may be experienced by others as being restless or difficult to keep up with)
    • Talks excessively
  • Impulsivity
    • Blurts out an answer before a question has been completed (e.g. completes people’s sentences; cannot wait for turn in conversation)
    • Trouble waiting for his / her turn (e.g. while waiting in line)
    • Interrupts or intrudes on others (e.g. butts into conversations, games, or activities; may start using other people’s things without asking or receiving permission; for adolescents and adults, may intrude into or take over what others are doing)
Symptoms during childhood Several inattentive or hyperactive–impulsive symptoms must have been present <12 y/o
Symptoms in multiple settings Several symptoms must be present in at least 2 settings, such as:

  • Home
  • School or university
  • Work
  • With friends or relatives
  • During other activities
Functional impairment Symptoms must:

  • Interfere with functioning, or
  • Reduce the quality of social, educational, or occupational functioning
Exclusion criteria The symptoms must:

  • Not occur exclusively during schizophrenia or another psychotic disorder
  • Not be better explained by another mental disorder, such as:
    • Mood disorder
    • Anxiety disorder
    • Dissociative disorder
    • Personality disorder
    • Substance intoxication or withdrawal

Complications and Prognosis

Complications include: [Ref]

  • Quality of life and social impairment
  • Educational underachievement, lower employment rates, reduced earnings
  • Higher risk of accidental injuries (e.g. vehicle crashes, head trauma, burns)
  • Significantly higher risk of suicidal ideation, attempts and completed suicide
  • Higher risk of criminal convictions and victimisation (making false police confessions and being a victim of violent or sexual crimes)
  • Higher risk of impulsive behaviours (e.g. gambling, reckless spending), substance misuse
  • Higher risk of teenage pregnancy
  • Higher risk of developing dementia in adulthood

Management

<5 y/o

If a child or young person presents in primary care with suggestive ADHD that is adversely impacting their development or family life, consider:

  • Watchful waiting for up to 10 weeks
  • Offer referral to group-based, ADHD-focused support, which does not require a formal diagnosis to begin

If the symptoms persist and continue to cause at least moderate impairment after this 10-week period, refer to secondary care (e.g. child psychiatrist, paediatrician, or specialist ADHD CAMHS) for a full assessment

1st line management for diagnosed ADHD: conservative management

  • Environmental modifications, such as
    • Changing seating arrangement in class to minimise distractions
    • Adjusting lighting and noise levels (e.g. using headphones)
    • Optimising work or education routines to feature shorter periods of focus paired with movement breaks (e.g. using “I need a break” cards)
  • Offer ADHD-focused group parent-training programme to the parents or carers

Do not routinely offer pharmacological treatment for ADHD to children who are <5 y/o

Young People

If a child or young person presents in primary care with suggestive ADHD that is adversely impacting their development or family life, consider:

  • Watchful waiting for up to 10 weeks
  • Offer referral to group-based, ADHD-focused support, which does not require a formal diagnosis to begin

If the symptoms persist and continue to cause at least moderate impairment after this 10-week period, refer to secondary care (e.g. child psychiatrist, paediatrician, or specialist ADHD CAMHS) for a full assessment

Management of formally diagnosed ADHD:

Step / indication Management
1st line Conservative management

  • Environmental modifications, such as
    • Changing seating arrangement in class to minimise distractions
    • Adjusting lighting and noise levels (e.g. using headphones)
    • Optimising work or education routines to feature shorter periods of focus paired with movement breaks (e.g. using “I need a break” cards)
  • Provide the parents and carers with ADHD-focused information, education and support

Formal parent training should only be offered if the patient also has oppositional defiant disorder or conduct disorder in addition to ADHD

2nd line (if there is significant impairment despite conservative management) Pharmacological management

  • 1st line: methylphenidate
  • 2nd line: lisdexamfetamine
  • 3rd line: atomoxetine / guanfacine
3rd line (if there is significant impairment despite pharmacological management) Psychological intervention

CBT can be considered in those who benefit from medications but still experience significant impairment

Adults

Step / indication Management
1st line Conservative management with environmental modifications, such as

  • Adjusting lighting and noise levels (e.g. using headphones)
  • Optimising work or education routines to feature shorter periods of focus paired with movement breaks
  • Reinforcing verbal requests with written instructions
2nd line (if there is significant impairment despite conservative management) Pharmacological management

  • 1st line: methylphenidate or lisdexamfetamine
  • 2nd line:
    • Dexamfetamine (if lisdexamfetamine is effective but its long-acting effect profile is not tolerated)
    • Atomoxetine (if both methylphenidate and lisdexamfetamine are not appropriate)
3rd line Psychological intervention (structured supportive psychological intervention with regular follow-up +/- CBT)

Specifically indicated in ANY of the following:

  • The patient chooses not to take medications
  • Medications are not appropriate (e.g. difficult adherence, ineffective, intolerable)
  • As a combination treatment, if the patient benefited from the medication but symptoms are still causing significant impairment

Monitoring ADHD Medications

Pre-treatment (baseline) assessment
  • Measure baseline height, weight, pulse and BP
  • Referral to specialist + ECG is necessary if the patient has high cardiac risk

NICE noted that a routine ECG is NOT necessary

Ongoing monitoring
  • Measure height every 6 months + measure weight every 3-6 months
  • Measure heart rate and BP before and after each dose change + every 6 months
  • Monitor for
    • Sleep patterns and behavioural responses
    • Development of tics (mainly a side effect of stimulants e.g. methylphenidate)
    • Seizures
    • Sexual dysfunction (mainly a side effect of atomoxetine)

NICE noted routine blood tests and ECGs are NOT recommended during ongoing treatment (unless there is a specific clinical indication)

References

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.